Angioplasty Balloon Market: Future Prospects and Demand 2024-2032
The global angioplasty balloon market is projected to expand from USD 3.05 billion in 2023 to USD 4.18 billion by 2031, reflecting a compound annual growth rate (CAGR) of 4.01% during the forecast period of 2024-2031.
Market Overview
Angioplasty balloons are critical medical devices employed in minimally invasive procedures to dilate narrowed or obstructed blood vessels, thereby enhancing blood flow. The increasing prevalence of cardiovascular diseases (CVDs), coupled with technological advancements in medical imaging and device design, are key factors driving the market's growth. According to the World Health Organization, CVDs account for approximately 32% of all global deaths, underscoring the urgent need for effective treatment options.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/3084
Regional Analysis
The angioplasty balloon market exhibits varied growth patterns across different regions:
- North America: This region holds a significant market share, attributed to a high incidence of CVDs, advanced healthcare infrastructure, and substantial investments in research and development.
- Europe: Europe follows closely, with growth driven by an aging population and increased healthcare expenditure.
- Asia-Pacific: The Asia-Pacific region is anticipated to witness the highest CAGR, propelled by a large patient pool, improving healthcare facilities, and rising awareness about minimally invasive procedures. Notably, in countries like India, Japan, and China, the cost of angioplasty balloons has reduced by approximately 40% over the last decade, indicating a growing market.
Market Segmentation
The angioplasty balloon market is segmented based on product type, application, and end-users:
- By Product Type:
- Normal Balloons
- Cutting/Scoring Balloons
- Drug-Eluting Balloons
- By Application:
- Coronary Angioplasty
- Peripheral Angioplasty
- By End-Users:
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
Key Players
The major players are Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis (Cardinal Health), CTK biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V, Medtronic Plc, MicroPort Scientific Corporation, and Nipro Medical Corporation, and others.
Key Highlights
- The market is expected to grow at a CAGR of 4.01% from 2024 to 2031.
- Technological advancements, such as the development of drug-eluting balloons, are enhancing treatment efficacy.
- The rising global prevalence of cardiovascular diseases is a primary driver of market expansion.
- North America and Europe currently dominate the market, while the Asia-Pacific region is projected to experience the fastest growth.
Future Outlook
The angioplasty balloon market is poised for sustained growth, driven by continuous technological innovations and the escalating burden of cardiovascular diseases worldwide. The shift towards minimally invasive procedures, coupled with increasing healthcare investments in emerging economies, is expected to create lucrative opportunities for market players. However, challenges such as high procedural costs and limited awareness in developing regions may impede market growth.
Conclusion
In conclusion, the angioplasty balloon market is on a robust growth trajectory, supported by technological advancements and a rising prevalence of cardiovascular conditions. Stakeholders, including manufacturers, healthcare providers, and policymakers, must collaborate to address existing challenges and ensure the widespread adoption of these life-saving devices.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian